DexCom, Inc. Stock News
$70.43
2.07%
yesterday
Nasdaq,
Sep 20, 10:14 pm CET
DexCom, Inc. Stock News
Neutral
PRNewsWire
●
14 days ago
LOS ANGELES , Sept. 6, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM).
Neutral
PRNewsWire
●
15 days ago
NEW YORK , Sept. 6, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the "Class Period").
Neutral
GlobeNewsWire
●
16 days ago
SAN FRANCISCO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Neutral
PRNewsWire
●
16 days ago
LOS ANGELES , Sept. 5, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Neutral
PRNewsWire
●
16 days ago
NEW YORK , Sept. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
Neutral
Seeking Alpha
●
17 days ago
DexCom, Inc. (NASDAQ:DXCM ) Wells Fargo 2024 Healthcare Conference September 4, 2024 11:00 AM ET Company Participants Kevin Sayer - Chairman, President, and CEO Jereme Sylvain - CFO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Lawrence Biegelsen All right. Welcome back everyone.
Neutral
Business Wire
●
17 days ago
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at an upcoming symposium during the European Association for the Study of Diabetes (EASD) Conference on Monday, 9th September, 1300 – 1430 CEST. The symposium will fe...
Neutral
PRNewsWire
●
18 days ago
LOS ANGELES , Sept. 3, 2024 /PRNewswire/ -- The Law Offices of Frank R.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
